Glioma Cells With Genetically Engineered IGF-I Receptor Downregulation Can Persist in the Brain in a Dormant State
Glioblastoma multiforme is an aggressive malignancy, resistant to standard treatment modalities and associated with poor prognosis. We analyzed the role of the IGF system in intracerebral glioma growth using human and rat glioma cells. The glioma cells C6 and U87MG were transduced with a genetically...
Main Authors: | Amir A. Samani, Josephine Nalbantoglu, Pnina Brodt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.555945/full |
Similar Items
-
Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug
by: Yinhsuan Michely Chen, et al.
Published: (2020-04-01) -
Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells
by: Jennifer Tsui, et al.
Published: (2021-04-01) -
Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation
by: Marvin A. Böttcher, et al.
Published: (2018-04-01) -
TMS-Induced Controlled BBB Opening: Preclinical Characterization and Implications for Treatment of Brain Cancer
by: Udi Vazana, et al.
Published: (2020-10-01) -
Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors
by: Crosato Milena, et al.
Published: (2006-04-01)